Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | KIF11 | P52732 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL263147 | 0.97 | KIF11 (0.43) | GAAKDM4EATML3MBTL1SIRT2 | |
| SCHEMBL262918 | 0.92 | KIF11 (0.47) | GAAKDM4ESIRT2ADORA3ADORA1 | |
| SCHEMBL263003 | 0.92 | SIRT2 (0.41) | GAAKDM4ESIRT2HTTKIF11 | |
| SCHEMBL13314097 | 0.90 | L3MBTL1 (0.48) | GAAKDM4EATML3MBTL1HPGD | |
| SCHEMBL20879854 | 0.90 | KIF11 (0.42) | GAAKDM4ESIRT2ADORA3ADORA1 | |
| SCHEMBL263094 | 0.90 | KDM4E (0.47) | KDM4EATML3MBTL1HTTKIF11 | |
| SCHEMBL15435796 | 0.89 | L3MBTL1 (0.47) | GAAKDM4EATML3MBTL1HPGD | |
| SCHEMBL19730368 | 0.88 | L3MBTL1 (0.55) | GAAKDM4EATML3MBTL1HPGD | |
| SCHEMBL27058876 | 0.88 | L3MBTL1 (0.46) | GAAKDM4EATML3MBTL1HTT | |
| SCHEMBL17754614 | 0.88 | L3MBTL1 (0.55) | GAAKDM4EATML3MBTL1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8816098-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using the anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-08-26 | — | — | US | disclosed |
| US-8530672-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-09-10 | — | — | US | disclosed |
| US-20120309984-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-12-06 | — | — | US | disclosed |
| US-8278655-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-02 | — | — | US | disclosed |
| EP-1972619-B1 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LAB (JP) | 2012-08-15 | — | — | EP | disclosed |
| US-8134147-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-03-13 | — | — | US | disclosed |
| US-8134147-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-03-13 | — | — | US | disclosed |
| US-20100200847-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-08-12 | — | — | US | disclosed |
| US-20100200847-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-08-12 | — | — | US | disclosed |
| US-7723722-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-05-25 | — | — | US | disclosed |
| US-7723722-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-05-25 | — | — | US | disclosed |
| EP-1972619-A1 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-09-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120309984-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE | CYP1A1, XPO7, AMY1A | GAA 754/4885KDM4E 3122/4885ATM 1087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.